11282-Lymphomas-Hodgkins-1240

Lymphomas

A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) and CD30-expressing peripheral T-cell lymphoma (PTCL) in adults age 60 and above

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Hodgkins
USOR Number: 11282

  • Address

603 N Wilmot Rd, Suite 151
Tucson, AZ 85711
P: (520) 886-0206

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.